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1. CLINICAL IMAGE {#ccr32648-sec-0001}
=================

A 60‐year‐old Caucasian woman with a past medical history of essential hypertension and chronic obstructive pulmonary disease presented with a 5‐day history of a widespread pruritic, striking erythematous to purple targetoid eruption on her trunk, neck, upper, and lower limbs (Figures [1](#ccr32648-fig-0001){ref-type="fig"} and [2](#ccr32648-fig-0002){ref-type="fig"}). She also complained of fatigue. She had been started on hydroxychloroquine (HCQ) 200 mg twice daily 19 days prior to presentation for arthritis. Histology of a skin biopsy from the left arm revealed interface dermatitis and eosinophil infiltrates. Hydroxychloroquine was discontinued from the day of admission, and the patient was initially started on treatment with intravenous prednisolone 62.5 mg once daily that was gradually reduced over a 6‐week period. At the time of discharge, 4 weeks later, most of the lesions had subsided and after 8 weeks, her skin appeared normal.

![Typical targetoid lesions on the right arm](CCR3-8-578-g001){#ccr32648-fig-0001}

![Widespread violaceous to erythematous plaques on the trunk of the patient](CCR3-8-578-g002){#ccr32648-fig-0002}

1.1. What is your diagnosis? {#ccr32648-sec-0002}
----------------------------

Hydroxychloroquine‐induced erythema multiforme.

2. DISCUSSION {#ccr32648-sec-0003}
=============

Severe cutaneous reactions to hydroxychloroquine are uncommon[1](#ccr32648-bib-0001){ref-type="ref"}, [2](#ccr32648-bib-0002){ref-type="ref"} However, as in this case, drug hypersensitivity reactions often manifest in skin. Because of the extensive use of HCQ in the treatment of numerous dermatologic and rheumatologic conditions, because no specific therapy is available, and because correct diagnosis generally leads to spontaneous resolution once the causative drug is withdrawn, clinicians should keep the possibility of this rare but severe, extensive, and acute reaction in mind.
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